Class II
Terminated
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
This recall has been terminated (originally issued March 6, 2013).
- Company
- Pacira Pharmaceuticals, Inc.
- Recall Initiated
- December 17, 2012
- Posted
- March 6, 2013
- Recall Number
- D-168-2013
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 324 vials
- Firm Location
- San Diego, CA, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Subpotent; bupivacaine
Distribution
Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.
Lot / Code Info
Lot #11-2005 Control #23542 Manufacture Date: 05Dec11 2011-L-009
More recalls by Pacira Pharmaceuticals, Inc.
Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only,...
Jul 3, 2024 · Class II
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026